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The incidence of osteonecrosis was 24% in 248 patients who had received 
262 kidney transplants 1971-1982. However, based only on patients a t  
risk, i.e. alive with functioning transplants, the incidence a t  1, 3 and 6 
years was found to be 13,27 and 36%; after six years no new cases were 
found. The relative increase in body-weight a t  180 days was predictive as 
regards risk for osteonecrosis, while the cumulative dose of steroids was 
not. This suggests that individual sensitivity to steroids rather than the 
absolute cumulative dose is involved in the development of osteonecrosis. 
The etiology of femoral head necrosis asso- 
ciated with renal transplantation is still 
controversial, corticosteroids and pre-existing 
osteodystrophy being the most likely causes, 
although post-transplant tertiary hyperpara- 
thyroidism may also play a role. We evaluated 
the incidence of osteonecrosis (ON) in the first 
248 renal transplant patients at the University 
Hospital Rotterdam-Dijkzigt. The relation- 
ships between ON and other factors, like cum- 
ulative corticosteroid dose, increase in body 
weight and some biochemical parameters, 
were also studied. 
Patients and methods 
We reviewed the records of 248 patients, who re- 
ceived a total of 262 kidney transplants between 
1971 and 1982. 
Immunosuppressive treatment consisted of azath- 
ioprine ( 2 3  mg/kg body weight) and prednisone (30 
mg) from the day of transplantation Rejection epi- 
sodes, diagnosed in 90 per cent of the patients, were 
treated both by increasing the oral steroid dose and 
by i.v. administration of methyl-prednisolone. 
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For further analysis, 189 patients (127 male and 
62 female) a t  risk for more than 1 year (alive with 
functioning transplant) were studied. The follow-up 
period ranged from 1-10 years. 
Radiographic examinations of the hip and knee 
joints were routinely performed in the absence of 
complaints and more frequently when indicated. The 
diagnosis of ON was based on the radiographic ap- 
pearance of bone changes. The actuarial incidence of 
ON was determined by a modification of the life table 
method, as described by Merrell & Shulman (1955). 
For statistical analysis, the chi-square (x2) test and 
Student’s t-test were used. 
Results 
ON was diagnosed in 61 out of 248 patients. 
However, 59 patients were a t  risk for less than 
1 year and only two of them developed ON. In 
the remaining 189 patients ON was diagnosed 
in 59. 
The actuarial risk of developing ON at 1, 3 
and 6 years were 13,27 and 39 per cent. After 
6 years no new cases were diagnosed (Figure 
1). There were no differences for sex, recip- 
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Figure 1. The actuarial incidence of ON. 
ient's age, time on hemodialysis before trans- 
plantation and number of second transplants 
between patients with and without ON. Hips, 
knees and shoulders were the predominantly 
affected joints (Table 1). In 16 patients only one 
joint was affected, in the others two or more 
joints were affected. Twenty-nine of 59 pa- 
tients with ON had complaints before radio- 
graphic diagnosis with a median period of 3 (1- 
13) months. Four patients had ON without 
symptoms, and two of them developed symp- 
toms later on. 
The mean serum calcium and alkaline phos- 
patase levels, 3 and 6 months after transplan- 
tation, were not higher in transplant patients 
with ON than in those without. The mean se- 
rum phosphate levels a t  these intervals were 
not lower in the group with ON than in those 
without. In patients with ON 12 had hypercal- 
Table 1 .  Location of osfeonecrosis in 59 patients 
L Hip 
R Hip 
L Knee 
R knee 
Ankle 
L Shoulder 
R shoulder 
L Elbow 
R Elbow 
39 
28 
18 
14 
2 
17 
16 
1 
3 
50 
40 
30 
20 
1-10 
increase in body weight, percent 
Figure 2. Relative increase in body weight 180 days after trans- 
plantation and the incidence of ON. 
cemia 3 and 6 months after transplantation, 3 
had hypophosphatemia a t  3 months and none 
a t  6 months post-transplantation. The preva- 
lence of these biochemical abnormalities was 
not different in transplant patients with ON 
than in patients without ON. The number of 
parathyroidectomies because of hyperparathy- 
roidism was the same in both groups. The cum- 
ulative dose of steroids after transplantation 
was not different in patients with and without 
ON. The relative increase in body weight a t  6 
months after transplantation showed a strong 
positive correlation with the incidence of ON 
(Figure 2). There was no correlation with body 
weight a t  time of transplantation and the in- 
cidence of ON. 
Discussion 
The reported incidence of ON after renal trans- 
plantation i s  4-37 per cent (Cruess et  al. 1968, 
Harrington et  al. 1971, Nelson et al. 1971, 
Griffths et al. 1974, Ibels et al. 1978, Elmstedt 
1982, de Graaf et al. 1982). Definition of ON, 
observer error and the method of analysis may 
account for part of the difference. 
Of our 248 renal transplant patients 24 per 
cent developed ON. However, many patients 
lose their graft or die before they have the op- 
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portunity to develop ON. Calculating the ac- 
tuarial risk for ON is thus in our opinion a 
more appropriate method, and we therefore 
used a modification of the life table as de- 
scribed by Merrell & Shulman (1955) to de- 
termine the freedom-index of ON. With this 
method the incidence of ON is based only on 
patients a t  risk (alive with a functioning renal 
allograft). It then appeared that the risk for 
ON was almost twice the overall estimate, that 
only 50 per cent of the total number of ON 
cases developed in the first 2 years and that no 
new cases of ON developed later than 6 years 
after transplantation. 
Most authors agree that corticosteroids play 
a role in transplantation ON (Woods et al. 
1972, Briggs et al. 1972, Rerides et  al. 1975, 
Ibels et  al. 1978, Nixon 1983). The exact me- 
chanism is unknown, and even a correlation of 
the total dose of corticosteroids with the occur- 
rence of ON is still controversial. However, 
Harrington e t  al. (1977) and Nelson et  al. 
(1971) reported a significant reduction in the 
incidence of ON when the mean corticosteroid 
dose was reduced. 
De Graaf et al. (1982) found that the total 
amount of prednisone administered during the 
first months after transplantation correlated 
positively with the incidence of ON. On the 
other hand, in this and other reports (Cruess e t  
al. 1968, Bewick et al. 1976, Ibels et al. 19781, 
no differences were found in the total initial 
dose of prednisone between patients with and 
without ON. However, the individual suscepti- 
bility to corticosteroids may vary considerably 
(Ibels et al. 1978, Adinoff & Hollister 19831, 
and may therefore obscure dose effect correla- 
tions. The increase in body weight may be an  
indicator of the physical effects of corticoste- 
roids. Indeed, we found a correlation of ON and 
the increase in body weight 6 months after 
transplantation. 
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